Aptamer Group strikes deal with biotech firm for targeted genetic medicine development
Aptamer Group plc (AIM: APTA), a pioneering developer of Optimer binders, has announced a substantial agreement with an undisclosed biotechnology company focused on genetic medicine development. This collaboration underscores Aptamer Group’s growing influence in innovating life sciences through their cutting-edge technology. Crafting Targeted Solutions for Genetic Medicines Under this agreement, Aptamer Group will utilize its […]